Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer. 1985;56(5):1106–11.
Article
CAS
PubMed
Google Scholar
Gerstner ER, Batchelor TT. Antiangiogenic therapy for glioblastoma. Cancer J. 2012;18(1):45–50. doi:10.1097/PPO.0b013e3182431c6f.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005;76(1):42–51. doi:S0002-9297(07)62542-7.
Article
CAS
PubMed
Google Scholar
Guclu B, Ozturk AK, Pricola KL, Bilguvar K, Shin D, O'Roak BJ, et al. Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery. 2005;57(5):1008–13. doi:00006123-200511000-00020.
Article
PubMed
Google Scholar
Petit N, Blecon A, Denier C, Tournier-Lasserve E. Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr Patterns. 2006;6(5):495–503. doi:S1567-133X(05)00143-2.
Article
CAS
PubMed
Google Scholar
Tanriover G, Boylan AJ, Diluna ML, Pricola KL, Louvi A, Gunel M. PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit. Neurosurgery. 2008;62(4):930–8. doi:10.1227/01.neu.0000318179.02912.ca. discussion 8.
Article
PubMed
Google Scholar
Draheim KM, Fisher OS, Boggon TJ, Calderwood DA. Cerebral cavernous malformation proteins at a glance. J Cell Sci. 2014;127(Pt 4):701–7. doi:10.1242/jcs.138388.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest. 2011;121(5):1871–81. doi:10.1172/JCI44393.
Article
CAS
PubMed
PubMed Central
Google Scholar
He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H, et al. Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal. 2010;3(116):ra26. doi:10.1126/scisignal.2000722.
Article
PubMed
PubMed Central
Google Scholar
Voss K, Stahl S, Schleider E, Ullrich S, Nickel J, Mueller TD, et al. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics. 2007;8(4):249–56. doi:10.1007/s10048-007-0098-9.
Article
CAS
PubMed
Google Scholar
Yoruk B, Gillers BS, Chi NC, Scott IC. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease. Dev Biol. 2011;362(2):121–3. doi:10.1016/j.ydbio.2011.12.006.
Article
PubMed
Google Scholar
Riant F, Bergametti F, Fournier HD, Chapon F, Michalak-Provost S, Cecillon M, et al. CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas. Mol Syndromol. 2013;4(4):165–72. doi:10.1159/000350042msy-0004-0165.
CAS
PubMed
PubMed Central
Google Scholar
Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015;17(3):188–96. doi:10.1038/gim.2014.97.
Article
CAS
PubMed
Google Scholar
Louvi A, Chen L, Two AM, Zhang H, Min W, Gunel M. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci U S A. 2011;108(9):3737–42. doi:10.1073/pnas.1012617108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Louvi A, Nishimura S, Gunel M. Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration. Development. 2014;141(6):1404–15. doi:10.1242/dev.093526.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fidalgo M, Guerrero A, Fraile M, Iglesias C, Pombo CM, Zalvide J. Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress. J Biol Chem. 2012;287(14):11556–65. doi:10.1074/jbc.M111.320259.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lauenborg B, Kopp K, Krejsgaard T, Eriksen KW, Geisler C, Dabelsteen S, et al. Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis. APMIS. 2010;118(10):719–28. doi:10.1111/j.1600-0463.2010.02669.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schleider E, Stahl S, Wustehube J, Walter U, Fischer A, Felbor U. Evidence for anti-angiogenic and pro-survival functions of the cerebral cavernous malformation protein 3. Neurogenetics. 2011;12(1):83–6. doi:10.1007/s10048-010-0261-6.
Article
CAS
PubMed
Google Scholar
Chen L, Tanriover G, Yano H, Friedlander R, Louvi A, Gunel M. Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3. Stroke. 2009;40(4):1474–81. doi:10.1161/STROKEAHA.108.527135.
Article
PubMed
PubMed Central
Google Scholar
Lin C, Meng S, Zhu T, Wang X. PDCD10/CCM3 acts downstream of {gamma}-protocadherins to regulate neuronal survival. J Biol Chem. 2010;285(53):41675–85. doi:10.1074/jbc.M110.179895.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang H, Ma X, Deng X, Chen Y, Mo X, Zhang Y, et al. PDCD10 interacts with STK25 to accelerate cell apoptosis under oxidative stress. Front Biosci (Landmark Ed). 2012;17:2295–305. doi:4053.
Article
Google Scholar
Zhu Y, Wu Q, Xu JF, Miller D, Sandalcioglu IE, Zhang JM, et al. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations. Neurosurg Focus. 2010;29(3), E1. doi:10.3171/2010.5.FOCUS1090.
Article
PubMed
Google Scholar
Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, Leo C, et al. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A. 2004;101(24):9067–72. doi:10.1073/pnas.0402932101.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huerta S, Harris DM, Jazirehi A, Bonavida B, Elashoff D, Livingston EH, et al. Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol. 2003;22(3):663–70.
CAS
PubMed
Google Scholar
Fisher OS, Boggon TJ. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell Mol Life Sci. 2013;71(10):1881–92. doi:10.1007/s00018-013-1532-9.
Article
PubMed
PubMed Central
Google Scholar
You C, Sandalcioglu IE, Dammann P, Felbor U, Sure U, Zhu Y. Loss of CCM3 impairs DLL4-Notch signaling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. J Cell Mol Med. 2013;17(3):407–18. doi:10.1111/jcmm.12022.
Article
CAS
PubMed
PubMed Central
Google Scholar
El Hindy N, Keyvani K, Pagenstecher A, Dammann P, Sandalcioglu IE, Sure U, et al. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. Neuro Oncol. 2013;15(10):1366–78. doi:10.1093/neuonc/not071.
Article
PubMed
PubMed Central
Google Scholar
Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, et al. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem. 2010;285(16):11760–4. doi:10.1074/jbc.C109.097220.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li X, Zhang R, Zhang H, He Y, Ji W, Min W, et al. Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity. J Biol Chem. 2010;285(31):24099–107. doi:10.1074/jbc.M110.128470.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Liu H, Zhang Y, Ma D. cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene. Sci China C Life Sci. 1999;42(3):323–9. doi:10.1007/BF03183610.
Article
CAS
PubMed
Google Scholar
Chen PY, Chang WS, Chou RH, Lai YK, Lin SC, Chi CY, et al. Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner. BMC Mol Biol. 2007;8:2. doi:10.1186/1471-2199-8-2.
Article
PubMed
PubMed Central
Google Scholar
Gonzalez-Fernandez R, Morales M, Avila J, Martin-Vasallo P. Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy. Oncol Lett. 2012;3(6):1341–9. doi:10.3892/ol.2012.669.
CAS
PubMed
PubMed Central
Google Scholar
Chen PY, Chang WS, Lai YK, Wu CW. c-Myc regulates the coordinated transcription of brain disease-related PDCD10-SERPINI1 bidirectional gene pair. Mol Cell Neurosci. 2009;42(1):23–32. doi:10.1016/j.mcn.2009.05.001.
Article
CAS
PubMed
Google Scholar
Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 2004;64(3):920–7.
Article
CAS
PubMed
Google Scholar
Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest. 2004;84(4):397–405. doi:10.1038/labinvest.3700070.
Article
CAS
PubMed
Google Scholar
Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007;11(1):83–95. doi:10.1016/j.ccr.2006.11.021.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zalvide J, Fidalgo M, Fraile M, Guerrero A, Iglesias C, Floridia E, et al. The CCM3-GCKIII partnership. Histol Histopathol. 2013;28(10):1265–72. doi:HH-11-358.
CAS
PubMed
Google Scholar
Mian MK, Nahed BV, Walcott BP, Ogilvy CS, Curry WT. Glioblastoma multiforme and cerebral cavernous malformations: intersection of pathophysiologic pathways. J Clin Neurosci. 2011;19(6):884–6. doi:10.1016/j.jocn.2011.07.017.
Article
PubMed
Google Scholar
Zhang JY, Ming ZY, Wu AH. Is cerebral cavernous malformation a pre-glioma lesion? Chin Med J (Engl). 2012;125(24):4511–3.
Google Scholar
Wilson DM, Cohen B, Keshari K, Vogel H, Steinberg G, Dillon W. Case report: glioblastoma multiforme complicating familial cavernous malformations. Clin Neuroradiol. 2013;24(3):293–6. doi:10.1007/s00062-013-0249-3.
Article
PubMed
Google Scholar
Ehtesham M, Kabos P, Yong WH, Schievink WI, Black KL, Yu JS. Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation. Surg Neurol. 2003;60(1):80–2. discussion 3. doi:S0090301903000326.
Article
PubMed
Google Scholar